Combination Chemotherapy in Treating Patients With Recurrent or Refractory Leukemia

NCT00002588 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Leukemia

Interventions

DRUG: etoposide
DRUG: topotecan hydrochloride

Sponsor

Case Comprehensive Cancer Center

Collaborators

[object Object]